vs
Side-by-side financial comparison of Dexcom (DXCM) and KEMPER Corp (KMPR). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.1B, roughly 1.1× KEMPER Corp). Dexcom runs the higher net margin — 21.2% vs -0.7%, a 21.9% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -4.7%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -0.5%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Kemper Corporation is an American insurance provider with corporate headquarters located in Chicago, Illinois. With nearly $13 billion in assets, the Kemper family of companies provides insurance to individuals, families, and businesses.
DXCM vs KMPR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.1B |
| Net Profit | $267.3M | $-8.0M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | — |
| Net Margin | 21.2% | -0.7% |
| Revenue YoY | 21.6% | -4.7% |
| Net Profit YoY | 153.6% | -108.2% |
| EPS (diluted) | $0.67 | $-0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.1B | ||
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.0B | $1.2B | ||
| Q4 24 | $1.1B | $1.2B | ||
| Q3 24 | $994.2M | $1.2B | ||
| Q2 24 | $1.0B | $1.1B |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $-8.0M | ||
| Q3 25 | $283.8M | $-21.0M | ||
| Q2 25 | $179.8M | $72.6M | ||
| Q1 25 | $105.4M | $99.7M | ||
| Q4 24 | $151.7M | $97.4M | ||
| Q3 24 | $134.6M | $73.7M | ||
| Q2 24 | $143.5M | $75.4M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | — | ||
| Q3 25 | 20.1% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 12.9% | — | ||
| Q4 24 | 17.0% | — | ||
| Q3 24 | 15.3% | 11.2% | ||
| Q2 24 | 15.7% | 10.1% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | -0.7% | ||
| Q3 25 | 23.5% | -1.7% | ||
| Q2 25 | 15.5% | 5.9% | ||
| Q1 25 | 10.2% | 8.4% | ||
| Q4 24 | 13.6% | 8.2% | ||
| Q3 24 | 13.5% | 6.3% | ||
| Q2 24 | 14.3% | 6.7% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $-0.03 | ||
| Q3 25 | $0.70 | $-0.34 | ||
| Q2 25 | $0.45 | $1.12 | ||
| Q1 25 | $0.27 | $1.54 | ||
| Q4 24 | $0.37 | $1.51 | ||
| Q3 24 | $0.34 | $1.14 | ||
| Q2 24 | $0.35 | $1.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | — |
| Total DebtLower is stronger | — | $943.5M |
| Stockholders' EquityBook value | $2.7B | $2.7B |
| Total Assets | $6.3B | $12.5B |
| Debt / EquityLower = less leverage | — | 0.35× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | $371.2M | ||
| Q2 25 | $1.2B | $407.6M | ||
| Q1 25 | $904.9M | $545.3M | ||
| Q4 24 | $606.1M | $1.0B | ||
| Q3 24 | $621.2M | $696.9M | ||
| Q2 24 | $939.2M | $539.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $943.5M | ||
| Q3 25 | — | $943.1M | ||
| Q2 25 | — | $942.6M | ||
| Q1 25 | — | $942.1M | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $2.7B | ||
| Q3 25 | $2.7B | $2.7B | ||
| Q2 25 | $2.6B | $370.0M | ||
| Q1 25 | $2.3B | $366.0M | ||
| Q4 24 | $2.1B | $2.8B | ||
| Q3 24 | $2.0B | $2.8B | ||
| Q2 24 | $2.4B | $358.0M |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $12.5B | ||
| Q3 25 | $7.5B | $12.4B | ||
| Q2 25 | $7.3B | $12.6B | ||
| Q1 25 | $6.8B | $12.5B | ||
| Q4 24 | $6.5B | $12.6B | ||
| Q3 24 | $6.4B | $12.6B | ||
| Q2 24 | $6.8B | $12.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | — | 2.55× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | 0.50× | ||
| Q2 24 | — | 3.88× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $175.0M |
| Free Cash FlowOCF − Capex | — | $166.2M |
| FCF MarginFCF / Revenue | — | 14.7% |
| Capex IntensityCapex / Revenue | — | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $553.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $175.0M | ||
| Q3 25 | $659.9M | $139.9M | ||
| Q2 25 | $303.0M | $89.6M | ||
| Q1 25 | $183.8M | $180.0M | ||
| Q4 24 | $301.4M | $175.1M | ||
| Q3 24 | $199.5M | $141.9M | ||
| Q2 24 | $279.4M | $22.9M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $166.2M | ||
| Q3 25 | $579.4M | $133.4M | ||
| Q2 25 | $208.9M | $82.0M | ||
| Q1 25 | $96.8M | $172.3M | ||
| Q4 24 | $176.8M | $165.4M | ||
| Q3 24 | $88.3M | $131.4M | ||
| Q2 24 | $213.3M | $5.2M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 14.7% | ||
| Q3 25 | 47.9% | 10.8% | ||
| Q2 25 | 18.1% | 6.7% | ||
| Q1 25 | 9.3% | 14.4% | ||
| Q4 24 | 15.9% | 13.9% | ||
| Q3 24 | 8.9% | 11.1% | ||
| Q2 24 | 21.2% | 0.5% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 0.8% | ||
| Q3 25 | 6.7% | 0.5% | ||
| Q2 25 | 8.1% | 0.6% | ||
| Q1 25 | 8.4% | 0.6% | ||
| Q4 24 | 11.2% | 0.8% | ||
| Q3 24 | 11.2% | 0.9% | ||
| Q2 24 | 6.6% | 1.6% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | — | ||
| Q3 25 | 2.33× | — | ||
| Q2 25 | 1.69× | 1.23× | ||
| Q1 25 | 1.74× | 1.81× | ||
| Q4 24 | 1.99× | 1.80× | ||
| Q3 24 | 1.48× | 1.93× | ||
| Q2 24 | 1.95× | 0.30× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
KMPR
| Specialty Property Casualty Insurance Segment | $995.1M | 88% |
| Life Insurance Segment1 | $140.7M | 12% |
